Anti-virulence therapeutic strategies against bacterial infections: recent advances
- PMID:36504617
- PMCID: PMC9719373
- DOI: 10.18683/germs.2022.1328
Anti-virulence therapeutic strategies against bacterial infections: recent advances
Abstract
The emergence and increasing prevalence of multidrug-resistant pathogens has become a major global healthcare problem. According to the World Health Organization if these trends continue, mortality from infection in 2050 will be higher than that from cancer. Microorganisms have various resistance mechanisms against different classes of antibiotics that emphasize the need for discovery of new antimicrobial compounds to treat bacterial infections. An interesting and new strategy for disarming pathogens is antivirulence therapy by blocking bacterial virulence factors or pathogenicity. Therefore, the use of these new pathoblockers could reduce the administration of broad-spectrum antimicrobials and prevalence of resistant strains. This review provides an overview of the antivirulence strategies published studies between years 2017 and 2021. Most antivirulence strategies focused on adhesins, toxins and bacterial communication. Additionally, targeting two-component systems and ncRNA elements were also examined in some studies. These new strategies have the potential to replace traditional antimicrobial agents and can be used to treat infections, especially infections caused by resistant pathogens, by targeting virulence factors.
Keywords: Antivirulence therapeutics; antiadherence strategies; antibiofilm activity; antimicrobial resistance; non‐coding RNA; pathoblockers; quorum sensing; secretion systems; two-component systems; virulence factors.
GERMS.
Conflict of interest statement
Conflicts of interest: All authors – none to declare.
Similar articles
- Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections.Calvert MB, Jumde VR, Titz A.Calvert MB, et al.Beilstein J Org Chem. 2018 Oct 11;14:2607-2617. doi: 10.3762/bjoc.14.239. eCollection 2018.Beilstein J Org Chem. 2018.PMID:30410623Free PMC article.Review.
- The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.Brannon JR, Hadjifrangiskou M.Brannon JR, et al.Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016.Drug Des Devel Ther. 2016.PMID:27313446Free PMC article.Review.
- Chemical-mediated virulence: the effects of host chemicals on microbial virulence and potential new antivirulence strategies.Moulding PB, El-Halfawy OM.Moulding PB, et al.Can J Microbiol. 2024 Oct 1;70(10):405-425. doi: 10.1139/cjm-2024-0017. Epub 2024 Jun 21.Can J Microbiol. 2024.PMID:38905704Review.
- Antivirulence Strategies for the Treatment ofStaphylococcus aureus Infections: A Mini Review.Ford CA, Hurford IM, Cassat JE.Ford CA, et al.Front Microbiol. 2021 Jan 14;11:632706. doi: 10.3389/fmicb.2020.632706. eCollection 2020.Front Microbiol. 2021.PMID:33519793Free PMC article.Review.
- Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens.Qais FA, Shafiq A, Ahmad I, Husain FM, Khan RA, Hassan I.Qais FA, et al.Microb Pathog. 2020 Jul;144:104172. doi: 10.1016/j.micpath.2020.104172. Epub 2020 Mar 26.Microb Pathog. 2020.PMID:32224208
Cited by
- Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria.Matos RG, Simmons KJ, Fishwick CWG, McDowall KJ, Arraiano CM.Matos RG, et al.Int J Mol Sci. 2024 Jul 24;25(15):8048. doi: 10.3390/ijms25158048.Int J Mol Sci. 2024.PMID:39125622Free PMC article.
- Theoretical study of ArcB and its dimerization, interaction with anaerobic metabolites, and activation of ArcA.Padilla-Vaca F, de la Mora J, García-Contreras R, Ramírez-Prado JH, Vicente-Gómez M, Vargas-Gasca F, Anaya-Velázquez F, Páramo-Pérez I, Rangel-Serrano Á, Cuéllar-Mata P, Vargas-Maya NI, Franco B.Padilla-Vaca F, et al.PeerJ. 2023 Oct 13;11:e16309. doi: 10.7717/peerj.16309. eCollection 2023.PeerJ. 2023.PMID:37849831Free PMC article.
- Efficacy of ceftiofur N-acyl homoserine lactonase niosome in the treatment of multi-resistant Klebsiella pneumoniae in broilers.Hosny RA, El-Badiea ZA, Elmasry DMA, Fadel MA.Hosny RA, et al.Vet Res Commun. 2023 Dec;47(4):2083-2100. doi: 10.1007/s11259-023-10161-7. Epub 2023 Jul 10.Vet Res Commun. 2023.PMID:37430152Free PMC article.
- Immunosenescence: How Aging Increases Susceptibility to Bacterial Infections and Virulence Factors.Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, Kollia Z, Verykios VS, Nikolaou M.Theodorakis N, et al.Microorganisms. 2024 Oct 11;12(10):2052. doi: 10.3390/microorganisms12102052.Microorganisms. 2024.PMID:39458361Free PMC article.Review.
- Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacae.Barceló IM, Escobar-Salom M, Jordana-Lluch E, Torrens G, Oliver A, Juan C.Barceló IM, et al.Sci Rep. 2024 Jan 2;14(1):189. doi: 10.1038/s41598-023-50685-1.Sci Rep. 2024.PMID:38167986Free PMC article.
References
Publication types
Related information
LinkOut - more resources
Full Text Sources